Agoracom Blog Home

Posts Tagged ‘$TSXV’

« Older Entries
Newer Entries »

Namaste $N.ca Announces March 2018 Sales of C$1.24M Representing a 74% Year-on-Year Increase and Acquires 535 New Patients Representing a 142% Month-on-Month Increase $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:26 AM on Friday, April 6th, 2018

Nlogo

  • March net revenue C$1,249,670
    • 74% revenue increase in March 2018 when compared to March 2017
  • Namaste MD acquired 535 new medical cannabis patients on the NamasteMD platform
    • 142% month-over-month increase of patients
    • Company anticipates further acceleration of the growth
    • will be key driver of future revenue

VANCOUVER, British Columbia, April 06, 2018 —Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce March 2018 total unaudited net revenue as reported by the Company (including shipping revenues and after discounts and refunds) were C$1,249,670, representing a 74% revenue increase in March 2018 when compared to March 2017. Namaste’s management team is also pleased to report that the Company’s wholly owned subsidiary, Namaste MD Inc. (“NamasteMD”), has acquired 535 new medical cannabis patients on the NamasteMD platform, representing a 142% month-over-month increase of patients. NamasteMD allows patients to consult with doctors or nurse practitioners for medical cannabis in a simple and convenient platform from the comfort of their homes. The Company anticipates further acceleration of the growth in the NamasteMD patient network and expects that NamasteMD will be key driver of future revenue.

The table below display’s Namaste’s total gross sales by revenue channel.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments; “We are very pleased to be seeing the positive trend of monthly sales increases year-over-year. What is most exciting is our increasing rate of patient acquisition on NamasteMD. With minimal outside marketing we were quietly able to bring on nearly 1,000 patients by the end of the March. We are working on expanding our nurse practitioner team with our partners at O Cannabis we Stand on Guard for Thee Inc. (“O Cannabis”) to accommodate the anticipated growth of patients. We strongly believe that our patients will be a key to our success, along with our strategy to provide our patients with not only the best care but also the largest and best variety of medical cannabis products. We’re proud to be innovating the industry by changing the way that patients access medical cannabis and look forward to continued growth through both the medical cannabis and hardware platforms.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis sales licence (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

 

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Tags: , , , , ,
Posted in All Recent Posts, Featured, Medical Marijuana Stocks, Namaste Technologies Inc. | Comments Off on Namaste $N.ca Announces March 2018 Sales of C$1.24M Representing a 74% Year-on-Year Increase and Acquires 535 New Patients Representing a 142% Month-on-Month Increase $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Move to #EVs to be ‘dramatic’ for metals: Penny #PGM #Nickel $TN.ca $NAM.ca

Posted by AGORACOM-JC at 4:45 PM on Thursday, April 5th, 2018
  • Penny predicts a dramatic shift in commodity demand patterns as the electrification of the global economy continues to boost demand for the metals that Norilsk produces, particularly nickel and cobalt
  • Penny noted that hybrid battery vehicles in the United States currently account for 9% of the market, with annual growth of 18%; battery EVs have around 3% market share but growth of 25%
  • Fuel cell EVs represent just 1% of the market but are growing at an annual pace of 41%

Andrea Hotter
[email protected]

NEW YORK — Norilsk Nickel chairman Gareth Penny gave his predictions for electric and hybrid vehicle growth and how the company will move to maximize the value of its products in an interview with Andrea Hotter in the April 2018 issue of Metal Market Magazine.

Penny predicts a dramatic shift in commodity demand patterns as the electrification of the global economy continues to boost demand for the metals that Norilsk produces, particularly nickel and cobalt.

“Like most of these things, the move to [electric vehicles] will take longer than people think, but when the time arrives it’ll be even more dramatic,” he said.

Penny noted that hybrid battery vehicles in the United States currently account for 9% of the market, with annual growth of 18%; battery EVs have around 3% market share but growth of 25%. Fuel cell EVs represent just 1% of the market but are growing at an annual pace of 41%.

Although Norilsk is synonymous with nickel production, roughly 27% of the company’s revenue actually comes from the metal compared with 30% from palladium. With around 8% of Norilsk’s revenue coming from platinum, more than one-third of its earnings come from platinum group metals.

Penny remains unperturbed about the potential loss of demand for palladium  – his top commodity pick currently despite his self-confessed love for diamonds – due to the elimination of catalytic converters as the world electrifies its cars. This is largely because he expects the biggest absolute growth in the next 10 years to be in hybrid vehicles.

“You cannot make a diesel engine a hybrid as you need a very light engine, which is by definition a petrol engine. Palladium is the catalytic converter of choice for petrol engines, while platinum is for diesel,” he said. “We are confident that in the next 10 years, demand for palladium in hybrid vehicles is going to grow very rapidly and probably outstrip the absolute growth of battery and fuel cell EVs.”

Norilsk might even get involved in new areas of the battery production chain, Penny said, with a joint venture its likely method of entry.

“Norilsk will definitely look at some form of partnership at different levels in the industry in order to maximize the value of its product. That’s something we’re actively considering at the moment,” he said. “I don’t know about developing batteries, but we’re looking very carefully at working with European chemical company BASF, with whom we’ve had relationships before.”

Source: http://www.amm.com/Article/3798827/Nonferrous/Move-to-EVs-to-be-dramatic-for-metals-Penny.html

Tags: , , , , ,
Posted in New Age Metals, Tartisan Resources | Comments Off on Move to #EVs to be ‘dramatic’ for metals: Penny #PGM #Nickel $TN.ca $NAM.ca

Namaste $N.ca Announces Share Purchase and Medical #Cannabis Licensed Dealer Application Letter of Intent With 2624078 Ontario Inc

Posted by AGORACOM-JC at 10:00 AM on Thursday, April 5th, 2018

Nlogo

  • Company has signed a non-binding letter of intent (“LOI”) with 2624078 Ontario Inc.
  • Namaste would acquire 51% of the share capital of 2624078 Ontario Inc., which will undertake an application to become a Licensed Dealer (“LD”) of medical cannabis, in accordance with Health Canada regulations

VANCOUVER, British Columbia, April 05, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has signed a non-binding letter of intent (“LOI”) with 2624078 Ontario Inc., whereby Namaste would acquire 51% of the share capital of 2624078 Ontario Inc., which will undertake an application to become a Licensed Dealer (“LD”) of medical cannabis, in accordance with Health Canada regulations. Licensed dealers are authorized to perform research and development, analytical testing and conducting clinical studies with medical cannabis as well as importing medical cannabis for research purposes. The location for the LD facility is at 7 Canso Road in Etobicoke, Ontario and directly across the street from Namaste’s wholly owned subsidiary, Cannmart Inc.’s Access to Cannabis for Medical Purposes (“ACMPR”) facility. The purpose of Namaste’s investment and partnership with 2624078 Ontario Inc. is to facilitate research and development of medical cannabis extracts as well as for testing of imported medical cannabis products in accordance with ACMPR guidelines. Namaste’s partnership with 2624078 Ontario Inc. reinforces Namaste’s position as a leader in the medical cannabis industry and helps ensure that it will be a first-mover in the research and production of cannabis concentrates as it anticipates a growing demand for extracts in the future.

Key LOI Terms:

  • Namaste will acquire 51% of the share capital of 2624078 Ontario Inc.
  • Namaste and will provide debt financing of up to $750,000 CAD to complete construction of the LD facility.
  • 2624078 Ontario Inc.’s existing management team will sign 3-year management agreements to provide operational oversight of the facility.
  • Both parties will have 30 days from the date of execution of the LOI to negotiate terms of definitive documentation which will include a share purchase agreement and management agreements.
  • The facility at 7 Canso Road will be constructed to meet ACMPR standards

The LOI and proposed share purchase agreement represent a significant milestone for Namaste in securing a facility that will facilitate the importation of unique strains of medical cannabis for testing purposes, as well as research and production of high potency cannabis extracts.  If an LD license is obtained, Namaste will be able to import medical cannabis from international partners for the purpose of testing the product against ACMPR standards. In addition to providing the ability to import medical cannabis for research purposes, the LD license would also allow Namaste to begin research and development of medical cannabis extracts. Currently, the Company estimates that cannabis extract sales in the US represent over 50% of all dispensary sales. As Namaste anticipates further expansion of Canada’s legal medical cannabis platform, it expects to see significant industry trends towards these higher potency products. This LOI and the implications of obtaining an LD license for Namaste would ensure the Company’s position in what it expects to become a strong segment of the Canadian medical cannabis industry in the future.

Management Commentary

Daniel Stern, President and CEO of 2624078 Ontario Inc. comments; “We are very excited to be working with Namaste on this project. We believe that our experience in cannabis extraction technology and many years of experience in the general cannabis industry will facilitate the success of this partnership with Namaste, who we believe is a leading innovator in the Canadian medical cannabis community.”

Sean Dollinger, President and CEO of Namaste comments; “We are very pleased to have signed this LOI as we feel confident in the future of medical cannabis extracts in the Canadian marketplace. Although high potency concentrates are not yet approved under ACMPR regulations, the LD license will provide Namaste with the opportunity to take the first steps towards not only researching and producing extracts but also engage in the process of importing medical cannabis for testing purposes. The management team of 2624078 Ontario Inc. has shown confidence in Namaste’s leadership abilities as demonstrated through our success in the industry to date. The launch of NamasteMD and our pending ACMPR sales license coupled with this LOI and the application for an LD license are important building blocks to solidify Namaste’s position as a leader in the Canadian medical cannabis industry.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Tags: , ,
Posted in All Recent Posts, Namaste Technologies Inc. | Comments Off on Namaste $N.ca Announces Share Purchase and Medical #Cannabis Licensed Dealer Application Letter of Intent With 2624078 Ontario Inc

betterU’s $BTRU.ca CEO to Speak at Global Leadership Summit in Singapore $ARCL $BPI $FC.ca

Posted by AGORACOM-JC at 8:54 AM on Thursday, April 5th, 2018

Betteru large

  • On April 13th 2018, Brad Loiselle, CEO of betterU along with 15 other global leaders were invited to speak at the HT-Mint Asia Leadership Summit in Singapore
  • Leadership Summit’s theme, The Road Ahead for Asia, will dive into the speakers’ viewpoints on future opportunities and advancements of the Asian markets
  • Will include active participation from over 300 invited leaders from industry, government, academia and world influencers.

OTTAWA, Ontario, April 05, 2018 — betterU Education Corp. (TSX-V:BTRU) (FRANKFURT:5OGA), (the “Corporation” or “betterU”), is pleased to announce that on April 13th 2018, Brad Loiselle, CEO of betterU, along with 15 other global leaders were invited to speak at the HT-Mint Asia Leadership Summit in Singapore. The Leadership Summit’s theme, The Road Ahead for Asia, will dive into the speakers’ viewpoints on future opportunities and advancements of the Asian markets, and will include active participation from over 300 invited leaders from industry, government, academia and world influencers.

Over the years, this event has included some of the world’s most well-known thought leaders and influences such as Nobel Peace Prize Winner His Holiness the Dalai Lama, the 43rd President of the United States George W. Bush, Former Prime Minister of the United Kingdom David Cameron, current Prime Minister of India Narendra Modi, Nobel Peace Prize Winner and 45th Vice President of the United States Al Gore, Bollywood actors Shah Rukh Khan, Amitabh Bachchan and Hollywood Actress Nicole Kidman. The knowledge, experience, and impact of such past HT Leadership Summits has created positive advancements in the world and this year will be no different. The highlighted 2018 speakers include:

  • Hon. Deputy Prime Minister of Singapore, Tharman Shanmugaratnam;
  • Former Prime Minister of the United Kingdom, The RT. Hon. Tony Blair;
  • Chairman of Tata Sons, Natarajan Chandrasekaran;
  • MP, Indian National Congress, Jyotiraditya Scindia;
  • CEO of betterU Education Corporation, Brad Loiselle;
  • Former Indian Cricket Captain, Sachin Tendulkar;
  • Chief Executive Officer International of Singtel, Arthur Lang;
  • Founder of the Isha Foundation, Sadhguru;
  • Actor and Producer, Aamir Khan;
  • Executive Chairman YCH Group, Dr. Robert Yap;
  • National University of Singapore, Prof. Wang Gungwu;
  • Former Foreign Secretary of India, Dr. Subrahmanyam Jaishankar;
  • National General Secretary, Janata Dal (United), Pavan K Varma;
  • National General Secretary, Bharatiya Janata Party, Ram Madhav;
  • Hon. Chief Minister of Andhra Pradesh, Nara Chandrababu Naidu; and
  • Hon, Minister of Road Transport, Highways, Shipping and Water Resources, River Development and Ganga Rejuvenation, India, Nitin Gadkari.

The 21st century has been dubbed the ‘Asian Century.’ Riding the crest of seemingly unstoppable growth, Asia’s rise has captured the popular imagination for three decades. By measures including gross domestic product, trade volumes, technological prowess and military capabilities, Asia has emerged as the world’s third pillar, of which Singapore, India and China are the success hotspots and power base.

“I am thrilled and honored to be counted amongst such a wonderful roster of speakers and to have the opportunity to bring forth my views on such important topics. India has the potential to be one of the world’s economic leaders and I look forward to my panel discussion on the Opportunities in the Emerging Business Ecosystems,” said Brad Loiselle, CEO of betterU.

About betterU

betterU, a global education to employment platform, aims to provide access to quality education from around the world to foster growth and opportunity to those who want to better their lives. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated education-to-employment ecosystem. betterU’s offerings can be categorized into several broad functions: to compliment school programs with flexible KG-12 programs preparing children for next stage of education, to provide access to global educational opportunities from leading educators, to foster an exceptional educational environment by providing befitting skills that lead to a better career, to bridge the gap between one’s existing education and prospective job requirement by training them and lastly, to connect the end user to various job opportunities.

www.betterU.ca and www.betterU.in

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release may contain forward-looking statements and information, which may involve risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Factors that might cause a difference include, but are not limited to, competitive developments, risks associated with betterU’s growth, the state of the financial markets, regulatory risks and other factors. There can be no assurance or guarantees that any statements of forward-looking information contained in this release will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral statements containing forward-looking information are based on the estimates and opinions of management on the dates they are made and expressly qualified in their entirety by this notice. Unless otherwise required by applicable securities laws, betterU disclaims any intention or obligation to update or revise any forward-looking statements, whether because of new information, future events or otherwise. Readers should not place undue reliance on any statements of forward-looking information that speak only as of the date of this release. Further information on betterU’s public filings, including their most recent audited consolidated financial statements, are available at www.sedar.com.

For further information, please visit  http://www.betteru.ca/investor-overview/

On behalf of the Board of Directors,
better Education Corp.
Brad Loiselle, CEO

For further information:

Investor Relations
1-613-695-4100 Ext. 233
Email: [email protected]

Tags: , , , , , , ,
Posted in All Recent Posts | Comments Off on betterU’s $BTRU.ca CEO to Speak at Global Leadership Summit in Singapore $ARCL $BPI $FC.ca

Monarques Gold $MQR.ca investigating potential game-changer for its wholly-owned Wasamac Gold project $MUX.ca $SII.ca

Posted by AGORACOM-JC at 8:48 AM on Thursday, April 5th, 2018

Monarquesgold hub large

  • Retained BBA to conduct a conceptual study for the transportation of gold-bearing material from the Wasamac deposit to an existing processing plant with an authorized tailings management facility in the region for custom milling

BBA retained to confirm Management’s strategy and to assess various options

MONTREAL, April 5, 2018 – MONARQUES GOLD CORPORATION (“Monarques” or the “Corporation”) (TSX-V: MQR) (OTCMKTS: MRQRF) (FRANKFURT: MR7) is pleased to announce that it has retained BBA to conduct a conceptual study for the transportation of gold-bearing material from the Wasamac deposit to an existing processing plant with an authorized tailings management facility in the region for custom milling. Since acquiring the Wasamac Gold project from Richmont Mines, Monarques’ management has been working towards unlocking the tremendous potential value of the project.

Monarques’ management has made it a priority to investigate any and all avenues to make Wasamac economical and profitable at a significantly lower gold price than the scenario that the previous owner was working with. A major breakthrough that Monarques has achieved is the realization that the Wasamac Gold project can be serviced by bulk, railcar transport. As such, Monarques could eliminate the extremely large capital outlay required to build a mill as it could potentially ship the Wasamac ore to any of a number of possible custom milling opportunities in the vicinity of Wasamac (see map of potential sites).

“We look forward to working with BBA to confirm our belief that the Wasamac Gold project could be profitable at a significantly lower gold price than what was envisioned under the previous owner. This is a potential game-changer for Monarques and its shareholders,” said Jean-Marc Lacoste, President and Chief Executive Officer of Monarques. “Following the update of the Wasamac resource estimate last October, which established a measured and indicated resource of 2,587,900 ounces of gold (see press release), we decided to look into the various possible operating scenarios, including custom milling. This study will allow us to collect data and information for the option of mining the Wasamac deposit using custom milling at one of the processing plants in Quebec and Ontario. This option has the advantage of significantly reducing the initial cost of the project as we would not have to build a mill or a tailings facility.”

The first phase of the study will establish an inventory of the main mining and processing sites in operation and accessible by road and/or rail in the Abitibi region, in both Ontario and Quebec, with their locations and qualifications. The second phase will develop a concept for the transportation of mineralization and/or treatment sludge for the three best options selected from the sites identified in the previous phase. The main goal of this phase is to design a concept for transporting the mineralization from the Wasamac deposit to a regional processing plant and tailings facility for custom milling. The Corporation expects to receive the results of this study in May 2018.

The technical and scientific content of this press release has been reviewed and approved by Marc-André Lavergne, P.Eng., the Corporation’s qualified person under National Instrument 43‑101.

ABOUT MONARQUES GOLD CORPORATION

Monarques Gold Corporation (TSX.V:MQR) is an emerging gold producer focused on pursuing growth through its large portfolio of high-quality projects in the Abitibi mining camp in Quebec, Canada. The Corporation currently owns close to 300 km² of gold properties (see map), including the Beaufor Mine, the Croinor Gold (see video), Wasamac, McKenzie Break and Swanson advanced projects, and the Camflo and Beacon mills, as well as six promising exploration projects. It also offers custom milling services out of its 1,600 tonne-per-day Camflo mill. Monarques enjoys a strong financial position and has more than 150 skilled employees who oversee its operating, development and exploration activities.

ABOUT BBA

BBA is a Canada-wide consulting engineering firm that offers multidisciplinary consulting services in engineering, project management and environment. Thanks to its cutting-edge expertise in the energy, mining and metals, biofuels, and oil and gas sectors, BBA is now recognized for the excellence of its services, from pre-study to onsite commissioning support and detailed engineering.

The firm relies on a team of over 750 professionals from its 11 offices across Canada to carry out local, national and international mandates, thereby helping its industrial clients implement the most reliable, profitable and eco-friendly solutions.

Forward-Looking Statements

The forward-looking statements in this press release involve known and unknown risks, uncertainties and other factors that may cause Monarques’ actual results, performance and achievements to be materially different from the results, performance or achievements expressed or implied therein. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Tags: , , ,
Posted in Monarques Gold | Comments Off on Monarques Gold $MQR.ca investigating potential game-changer for its wholly-owned Wasamac Gold project $MUX.ca $SII.ca

Esports Entertainment Group $GMBL Announces Winners Of Beta Test Competition On #VIE.gg #Esports Wagering Platform; All Participants To Receive 50 Euros Credit $ATVI $TTWO $GAME $EPY.ca

Posted by AGORACOM-JC at 8:44 AM on Thursday, April 5th, 2018

Esports large

  • Announced winners of the Beta Test Competition on VIE  (https://vie.gg) 
  • The world’s safest, most secure and transparent esports wagering platform.

ST. MARY’S, Antigua, April 05, 2018 – Esports Entertainment Group, Inc. (OTCQB:GMBL) (or the “Company”), a licensed online gambling company with a specific focus on esports wagering and 18+ gaming, is pleased to announce the winners of the Beta Test Competition on VIE  (https://vie.gg)  the world’s safest, most secure and transparent esports wagering platform.

VIE offers bet exchange style wagering on esports events in a licensed, regulated and secured platform to the global esports audience, excluding jurisdictions such as the USA that prohibit online gambling. VIE features wagering on the following esports games:

Counter-Strike: Global Offensive (CSGO)

  • Dota 2
  • Call of Duty
  • Hearthstone
  • StarCraft II

BETA TEST WINNERS AND PRIZES

Esports Entertainment Group congratulates our top three winners and wishes them great success going forward.  The Company would also like to thank all beta contest participants for their time and invaluable feedback that helped make VIE even better for our launch on March 20th.  All participants will have their accounts credited with 50 Euros.

Grant Johnson, CEO of Esports Entertainment Group stated, “I am very happy for Kevin, Andres and Karolis and very thankful to all of our amazing participants for the help they provided us in beta testing VIE prior to our launch. As a result of their feedback, we made changes to some of our wagering terminology, boosted our help page with videos, expanded our FAQs and fast tracked future features such as hosting live viewing of actual matches our players are betting on.  They earned their account credits and I look forward to watching them grow with VIE, including becoming affiliates to attract their networks and earn even more money as our partners.”

This press release is available on our Online Investor Relations Community for shareholders and potential shareholders to ask questions, receive answers and collaborate with management in a fully moderated forum at https://agoracom.com/ir/EsportsEntertainmentGroup

About Esports Entertainment Group

Esports Entertainment Group Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Initially, Esports Entertainment intends to offer bet exchange style wagering on esports events in a licensed, regulated and secured platform to the global esports audience, excluding the US and EU. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds licenses to conduct online gambling and 18+ gaming on a global basis, excluding the US and EU, in Curacao, Kingdom of the Netherlands and the Kahnawake Gaming Commission in Canada. The Company maintains offices in Antigua and Poland. Esports Entertainment common stock is listed on the OTCQB under the symbol GMBL.  For more information visit www.esportsentertainmentgroup.com
.
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

Corporate Finance Inquiries
Stephen Cotugno
Vice President, Corporate Development
[email protected]
201-220-5745

Investor Relations Inquiries
AGORACOM
[email protected]
http://agoracom.com/ir/eSportsEntertainmentGroup

Tags: , , , , , ,
Posted in Esports Entertainment Group, Esports Entertainment Group Inc. | Comments Off on Esports Entertainment Group $GMBL Announces Winners Of Beta Test Competition On #VIE.gg #Esports Wagering Platform; All Participants To Receive 50 Euros Credit $ATVI $TTWO $GAME $EPY.ca

INTERVIEW: $HPQ.ca Discusses MOU with Big Data Enterprise #Blockchain Solution Developer to Develop a Carbon Credit Marketplace for #Solar Carbon Credits $FSLR $SPWR $CSIQ $NEP

Posted by AGORACOM-JC at 6:32 PM on Wednesday, April 4th, 2018

Tags: , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, HPQ-Silicon Resources Inc. | Comments Off on INTERVIEW: $HPQ.ca Discusses MOU with Big Data Enterprise #Blockchain Solution Developer to Develop a Carbon Credit Marketplace for #Solar Carbon Credits $FSLR $SPWR $CSIQ $NEP

New Age Metals $NAM.ca Signs a Binding Letter of Intent (LOI) with Prominent Alaskan Geological Consulting Firm $WG.ca $XTM.ca $WM.ca

Posted by AGORACOM-JC at 9:55 AM on Wednesday, April 4th, 2018

New age large

  • Alaska has an extensive mineral inventory and is one of the leading states in America for mineral exploration and development.
  • New Age Metals (NAM) objective is to acquire Platinum Group Metals (PGM), PGM Polymetallic, and Rare Metal Projects in Alaska and has signed a binding Letter of Intent (LOI) with Avalon Development Corp., a prominent Alaskan geological consulting firm.
  • Avalon Development Corp. is a private company and a leader in mineral exploration and development in Alaska.
  • Avalon has agreed to share its extensive geological, geochemical, and geophysical database with New Age Metals (NAM) for 2 years, with the focus being on PGM, PGM Polymetallic, and Rare Metal Projects in Alaska.
  • According to the Fraser Institute’s 2017 survey of mining companies, Alaska ranks as the 10th best jurisdiction in the world for mining. In North America it stands as the 6th best mining jurisdiction behind only: Saskatchewan, Nevada, Quebec, Ontario and Arizona.
  • NAM has two green metals divisions and its major PGM focus is on the development of its 100% owned River Valley PGM Deposit, the largest undeveloped Primary PGM resource in North America, with 4.62Moz Pd Eq in Measured plus Indicated including an additional 2.7Moz Pd Eq in Inferred (see Mar. 21, 2018). River Valley is situated within 100 KMs of the world class Sudbury metallurgical complex.

April 4th, 2018 / Rockport, ON, Canada – New Age Metals Inc. (TSX.V: NAM; OTCQB: NMTLF; FSE: P7J.F) is pleased to announce that it has signed a binding Letter of Intent (“LOI”) with Avalon Development Corp. (“Avalon”). The LOI calls for an agreement between the companies whereby Avalon will provide acquisition and geological services to New Age Metals (“NAM”) in the state of Alaska. The LOI further defines the extent of the services as follows:

1.To provide NAM with its extensive geological, geochemical, and geophysical database on Platinum Group Metals (PGM’s), PGM Polymetallic, and Rare Metals for a minimum 2 years.

2. Avalon will provide field manager services to NAM in the event any new acquisitions are made as a result of the LOI agreement.

3.Avalon and/or its associated companies will receive finder’s fees and/or property option compensation for its services.

Mr. Harry Barr Chairman/CEO stated: “We are pleased to partner with Avalon Development Corp. and its President Mr. Curt Freeman in Alaska. The LOI accomplishes another milestone in 2018 for NAM which was to find a new mining jurisdiction and a qualified consulting group to help our company continue its search for green metals, PGM’s, and Rare Metals. In the event the company acquires one or more projects in the state of Alaska, we will utilize our Prospector Generator Model, which has been successful in our Lithium Division, and will seek out partners to help us develop our newly acquired projects.”

OPT-IN LIST

If you have not done so already, we encourage you to sign up on our website (www.newagemetals.com) to receive our updated news or click here.

About Avalon development Corp

Since its founding in 1985, Avalon Development has evolved along with the mineral industry and its clients. Avalon exploration teams participated in a number of discoveries in the state. Avalon was responsible for Alaska’s newest gold discovery, the +1 million ounce Peak zone deposit, as well as the 6.5 million ounce intrusive-hosted Dolphin gold deposit, initial targeting of the 20 million ounce Livengood deposit, the southwestern extension of the 1.3 million ounce True North deposit, and deep high grade gold resources at the historic Cleary Hill mine. Avalon has also been responsible for platinum group element, copper-nickel and rare metal discoveries on several exploration projects across Alaska. Avalon continues to work with a number of major and junior mining companies involved in precious, base and strategic metal exploration in Alaska.

ABOUT NAM’S PGM DIVISION

NAM’s flagship project is its 100% owned River Valley PGM Project (NAM Website – River Valley Project) in the Sudbury Mining District of Northern Ontario (100 km east of Sudbury, Ontario). Presently the River Valley Project is North America’s largest undeveloped primary PGM deposit with Measured + Indicated resources of 160 million tones @ 0.44 g/t Palladium, 0.17 g/t Platinum, 0.03 g/t Gold, with a total metal grade of 0.64 g/t at a cut-off grade of 0.4 g/t equating to 3,297,173 ounces PGM plus Gold and 4,626,250 PdEq Ounces. This equates to 4,626,250 PdEq ounces M+I and 2,713,933 PdEq ounces in inferred (figure 1). Having completed a 2018 NI-43-101 resource update the company is finalizing its 2018 exploration programs which will include geophysics, and extensive drill programs, which are all working towards the completion of a Preliminary Economic Assessment (PEA). Our objective is to develop a series of open pits (bulk mining) over the 16 kilometers of mineralization, concentrate on site, and ship the concentrates to the long-established Sudbury Metallurgical Complex.

ABOUT NAM’S LITHIUM DIVISION

The Company has five pegmatite hosted Lithium Projects in the Winnipeg River Pegmatite Field, located in SE Manitoba. Three of the projects are drill ready. This Pegmatite Field hosts the world class Tanco Pegmatite that has been mined for Tantalum, Cesium and Spodumene (one of the primary Lithium ore minerals) in varying capacities, since 1969. NAM’s Lithium Projects are strategically situated in this prolific Pegmatite Field. Presently, NAM is one of the largest mineral claim holders for Lithium in the Winnipeg River Pegmatite Field. On January 15th 2018, NAM announced an agreement with Azincourt Energy Corporation (see Jan 15, 2018 and Feb 22nd, 2018 Press Releases) whereby Azincourt will commit up to $3.85 million dollars in exploration, up to 3 million shares of Azincourt stock to NAM, up to $210,000 in cash, and a 2% net smelter royalty on all 5 projects. Exploration plans for 2018 are currently in progress, whereby a minimum of $500,000 will be expended this year.

QUALIFIED PERSON

The contents contained herein that relate to Exploration Results or Mineral Resources is based on information compiled, reviewed or prepared by Carey Galeschuk, a consulting geoscientist for New Age Metals. Mr. Galeschuk is the Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the technical content of this news release.

On behalf of the Board of Directors

“Harry Barr”

Harry G. Barr

Chairman and CEO

ADDITIONAL INFORMATION

Should you have additional inquiries, please contact Paul Poggione, Corporate Development, Tel: 1-613-659-2773, email: [email protected].

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.

Tags: , , ,
Posted in All Recent Posts, New Age Metals | Comments Off on New Age Metals $NAM.ca Signs a Binding Letter of Intent (LOI) with Prominent Alaskan Geological Consulting Firm $WG.ca $XTM.ca $WM.ca

Namaste $N.ca Announces Canada’s First Large-Scale National Prospective Observational Study to Observe the Impact of Medical #Cannabis Use for Anxiety Treatment $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:51 AM on Wednesday, April 4th, 2018

Nlogo

  • Initiated Canada’s first large-scale prospective study on a national platform called the Cannabis for Anxiety Reduction study, to determine the effectiveness of cannabis in reducing anxiety in study participants
  • One in four Canadians suffer from anxiety and the Company through this study will seek to gain valuable information from study participants on the impact of medical cannabis use in relation to their anxiety

VANCOUVER, British Columbia, April 04, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT: M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has initiated Canada’s first large-scale prospective study on a national platform called the Cannabis for Anxiety Reduction study, to determine the effectiveness of cannabis in reducing anxiety in study participants. One in four Canadians suffer from anxiety and the Company through this study will seek to gain valuable information from study participants on the impact of medical cannabis use in relation to their anxiety. Namaste is also interested in determining the safety profile of patients using medical cannabis, and whether strain and dose of medical cannabis may impact patient reductions in anxiety ratings. The study will be available to all Canadians and will be conducted under the following conditions:

  • Prospective patients must be over 25 years of age.
  • Patients must score 8 or above Hospital Anxiety and Depression Scale (HADS).
  • The study will span over a 3-month period for each registered patient.
  • The study will be submitted for approval to the Veritas Independent Review Board (IRB) prior to commencement.
  • The primary investigator in the study is a nurse practitioner.
  • Patients can self-refer into the study (without referral through a doctor or specialist).

Namaste plans to offer this study to its patients which are registered under the Company’s wholly-owned subsidiary and virtual patient platform, NamasteMD Inc. (“NamasteMD”). Patients suffering from anxiety under the terms outlined above may participate in the study. This study is the first large-scale anxiety study in the nation, establishing Namaste as an innovator in research related to anxiety and cannabis. This is also the first national study where the primary investigator is a nurse practitioner. The Company intends to conduct similar studies in various areas where patients can benefit from the use of medical cannabis. The data collected from the study is valuable for the Company as well as the industry as a whole. The study may be published in peer-reviewed research journals and other medical publications.

For more information on this study please email [email protected]

Management Commentary

Sean Dollinger, President and CEO of Namaste comments; “We are very pleased to have initiated this study with the help of our partners at O-Cannabis. As many people in Canada suffer from varying forms of anxiety, we believe that many of these patients can benefit from the use of medical cannabis instead of prescription pharmaceutical drugs. We hope this study will provide very valuable information for Namaste and for the industry. We encourage qualifying patients to participate and look forward to seeing the results. We plan to undertake additional studies to bring awareness and a better understanding of how medical cannabis can benefit Canadians. We believe that these studies will help Namaste by attracting a larger base of patients and help solidify Namaste’s position as a leader in the Canadian medical cannabis industry.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

 

Tags: , , , ,
Posted in All Recent Posts, Medical Marijuana Stocks, Namaste Technologies Inc. | Comments Off on Namaste $N.ca Announces Canada’s First Large-Scale National Prospective Observational Study to Observe the Impact of Medical #Cannabis Use for Anxiety Treatment $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Tetra Bio-Pharma $TBP.ca Initiates Enrollment of Patients in Phase 3 PPP001 Smokable Cannabis Pellet Study $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:58 AM on Wednesday, April 4th, 2018

Logo tetrabiopharma rgb web

  • Announced the initiation of screening and enrollment activities in the Phase 3 study of its PPP001 smokable cannabis pellet for advanced cancer patients with uncontrolled pain
  • Tetra authorized the initiation of the patient enrollment activities at its main clinical site, Santé Cannabis, a private medical cannabis clinic in Montreal which is in compliance with Health Canada Division 5 regulations and the International Conference on Harmonization (ICH) Good Clinical Practices (GCP) (E6) R2

1st Canadian Cannabis Smokable Pellet Study 1st Step Towards Pharmaceutical Distribution of Cannabis

OTTAWA, ONTARIO–(April 4, 2018) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP) (OTCQB:TBPMF), today announced the initiation of screening and enrolment activities in the Phase 3 study of its PPP001 smokable cannabis pellet for advanced cancer patients with uncontrolled pain.

Tetra authorized the initiation of the patient enrollment activities at its main clinical site, Santé Cannabis, a private medical cannabis clinic in Montreal which is in compliance with Health Canada Division 5 regulations and the International Conference on Harmonization (ICH) Good Clinical Practices (GCP) (E6) R2.

PPP001 aims to be the first smokable cannabis for advanced cancer pain available under prescription. It is a dried cannabis pellet designed to be smoked in an inhalation device specifically developed for this product. PPP001 is a unique blend of 3 strains of standardized dried cannabis, creating a drug substance with 9.5% THC and 2.5% CBD.

“This is a significant milestone in the lead product of our strong pipeline of cannabinoid-based drugs targeting patients with advanced pain,” said Guy Chamberland, Tetra’s CEO and CSO. “The launch of the Phase 3 clinical trial will be used to support the marketing application of PPP001 smokable pellet that is followed by four other cannabinoid-based products that we are developing using different delivery systems such as oral tablets, eye drops, topical ointments and oral capsules of cannabis oil.”

On February 28th, 2018, Santé Cannabis received authorization from the Office of Controlled Substances to use PPP001 (controlled substance) for the Phase 3 clinical trial. This authorization granted the Principal Investigator of the Phase 3 trial, Dr. Antonio Vigano, exemption from the application of several provisions of the Controlled Drugs and Substances Act and the Narcotic Control Regulations thereby allowing the investigator to proceed with the clinical study of PPP001 in advanced cancer patients. In addition, the exemption allows Santé Cannabis to store and dispense the study medication directly to the patients, a process not permitted by Licensed Producers under the ACMPR.

“We are performing the first large study of the safety and efficacy of a dried cannabis smoked drug in advanced cancer patients,” added Guy Chamberland. “Over the next month Tetra will expand the trial by working with other clinics across Canada. Most importantly, we believe this multisite study has the potential to change the current vision of the use of smoked cannabis as an effective palliative care therapy of patients with advanced cancer.”

About PPP001:

PPP001 aims to be the first smokable marihuana for advanced cancer pain under prescription. It is a dried cannabis pellet designed to be smoked in an inhalation device specifically developed for this product. PPP001 is a unique blend of 3 strains of standardized dried cannabis, creating a drug substance with 9.5% THC and 2.5% CBD.

About Tetra Bio-Pharma:

Tetra Bio-Pharma (TSX VENTURE:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products.

More information at: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Corporation believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Corporation’s ability to control or predict, that may cause the actual results of the Corporation to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the failure to obtain sufficient financing to execute the Corporation’s business plan; the success of the Rx Princeps™ product offering and inhalation device; guidance on expected sales volumes associated with the Rx Princeps™ product offering and inhalation device; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Corporation’s public disclosure record on file with the relevant securities regulatory authorities. Although the Corporation has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Dr. Anne-Sophie Courtois, DVM
Vice President, Marketing & Communications
(438) 899-7575

For media information, please contact:
Daniel Granger
[email protected]
ACJ Communication
O: 1 514 840 7990
M: 1 514 232 1556

For investors information, please contact:
[email protected]
(438) 504-5784

Tags: , , ,
Posted in All Recent Posts, Tetra Bio-Pharma Inc. | Comments Off on Tetra Bio-Pharma $TBP.ca Initiates Enrollment of Patients in Phase 3 PPP001 Smokable Cannabis Pellet Study $AERO $CBDS $CGRW $APH.ca $GBLX

« Older Entries
Newer Entries »